[A13-31] Addendum to Commission A13-17 (vildagliptin/metformin)
Last updated 01.10.2013
Project no.: A13-31
Commission: Commission awarded on 07.08.2013 by the Federal Joint Committee (G-BA).
Report type: Addendum
Status: Commission completed
Department/Division: Drug Assessment
Topic: Digestion, metabolism and hormones
Note:
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment
Federal Joint Committee (G-BA)
2013-10-01 A G-BA decision was published.